UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia. The VMD is aware of media reports and ...

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse ...

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse ...

Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, acknowledges receipt of a notice from Philotimo Fund, LP, an entity ...

Following Brexit, from 31st January 2020, the UK is no longer subject to EU single-market ... This arrangement means that medicinal products on the market in NI must be authorised in line with ...

In November 2024, the treatment received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP ... from Clarity AD for the presence of >4 microhemorrhages and additional ...

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions ...

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions ...

In a strategic move beyond traditional crops, ITC Limited is exploring avenues in the medicinal and aromatic products segment to focus on value-added agriculture. Leveraging its proven backend ...